SPY334.33+2.22 0.67%
DIA273.90+1.90 0.70%
IXIC11,108.07+109.67 1.00%

Galectin Therapeutics Q3 EPS $(0.05) Up From $(0.07) YoY

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.05) per share. This is a 28.57 percent increase over losses of $(0.07) per share from the same period last year.

Benzinga · -

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.05) per share. This is a 28.57 percent increase over losses of $(0.07) per share from the same period last year.